Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

14.81

+1.59 (12.03%)

At close: Aug 13, 2025, 4:00 PM

14.40

-0.41 (-2.77%)

Pre-market: Aug 14, 2025, 8:49 AM EDT

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $2.15 billion as of August 14, 2025. Its market cap has decreased by -38.12% in one year.

Market Cap

2.15B

Enterprise Value

1.22B

1-Year Change

-38.12%

Ranking

#1912

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.15B, an increase of 14.01%. That is a compound annual growth rate of 1.72%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	2.15B	-26.65%
Dec 31, 2024	2.93B	-1.10%
Dec 29, 2023	2.97B	-21.48%
Dec 30, 2022	3.78B	-30.66%
Dec 31, 2021	5.45B	-45.77%
Dec 31, 2020	10.04B	500.43%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
AstraZeneca	240.81B
Novartis AG	234.72B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings